Journal
Frontiers in Oncology
Publication Date
1-1-2021
Volume
11
First Page
728047
Document Type
Open Access Publication
DOI
10.3389/fonc.2021.728047
Rights and Permissions
Li R, Zeng X, Yang M, Feng J, Xu X, Bao L, Ye T, Wang X, Xue B and Huang Y (2021) Antidiabetic DPP-4 Inhibitors Reprogram Tumor Microenvironment That Facilitates Murine Breast Cancer Metastasis Through Interaction With Cancer Cells via a ROS–NF-кB–NLRP3 Axis. Front. Oncol. 11:728047. doi: 10.3389/fonc.2021.728047 © 2021 Li, Zeng, Yang, Feng, Xu, Bao, Ye, Wang, Xue and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Li, Rui; Zeng, Xin; Yang, Meihua; Feng, Jinmei; Xu, Xiaohui; Bao, Liming; Ye, Tingbo; Wang, Xin; Xue, Bingqian; and Huang, Yi, "Antidiabetic DPP-4 inhibitors reprogram tumor microenvironment that facilitates murine breast cancer metastasis through interaction with cancer cells via a ROS-NF-кB-NLRP3 axis." Frontiers in Oncology. 11, 728047 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11361
Supplementary Figures S1-S9
